Disease mongering: Expanding the boundaries of treatable disease

Internal Medicine Journal

Volumn 38, Issue 11, 2008, Pages 858-861

  Doran, E ^a   Henry, D ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Commercial promotion; Conflict of interest; Disease awareness; Disease mongering

Indexed keywords

CALCIUM ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADVERTIZING; AWARENESS; COMMERCIAL PHENOMENA; CONSUMER; DISEASE MANAGEMENT; DRUG INDUSTRY; DRUG MARKETING; E-MAIL; HEALTH CARE COST; HEALTH CARE INDUSTRY; INTERNET; MASS MEDIUM; MEDICAL TECHNOLOGY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TELEVISION;

AWARENESS; CONFLICT OF INTEREST; CONSENSUS; DISEASE MANAGEMENT; HUMANS; TREATMENT OUTCOME;

EID: 57649158390     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01814.x     Document Type: Review

References (22)

1. Payer L. Disease Mongers: How Doctors, Drug Companies and Insurers are Making You Feel Sick. New York : John Wiley 1992.
2. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002 324 : 886 91.
3. Healy D. Shaping the intimate: influences on the experience of everyday nerves. Soc Stud Sci 2004 34 : 219 45.
4. Healy D. The latest mania: selling bipolar disorder. PLoS Med 2006 3 : e185.
5. Phillips C. Medicine goes to school: teachers as sickness brokers for ADHD. PLoS Med 2006 3 : e182.
6. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS - Med 2006 3 : e178.
7. Maggini M, Vanacore N, Raschetti R. Cholinesterase inhibitors: drugs looking for a disease? PLoS - Med 2006 3 : e140.
8. Wolinsky H. Disease mongering and drug marketing: does the pharmaceutical industry manufacture diseases as well as drugs? EMBO Rep 2005 6 : 612 14.
9. Triggle DJ. Vaccines, Viagra and Vioxx: medicines, markets and money - when life-saving meets life-style. Drug Dev Res 2005 64 : 90 98.
10. Woloshin S, Schwarz LM. Giving legs to help restless legs: a case study of how the media helps make people sick. PLoS Med 2006 3 : e170.
11. Moynihan R, Henry D. The fight against disease mongering: generating knowledge for action. PLoS Med 2006 3 : e191.
12. Herxheimer A. Relationships between the pharmaceutical industry and patient organizations. BMJ 2003 326 : 1208 10.
13. Zuckerman D. Hype in health reporting: 'checkbook science' buys distortion of medical news. Int J Health Serv 2003 33 : 383 9.
14. Buckley J. Pharmaceutical marketing - time for change. EJBO 2004 9 : 4 10.
15. Tracey JF. Between discourse and being: the commodification of pharmaceuticals in late capitalism. Commun Rev 2004 7 : 15 34.
16. Puschmann T, Thalmann O, Alt R. Healthcare Portals - customer Triggle DJcentricity in the pharmaceutical industry. Global Co-Operation in the New Millennium The 9th European Conference on Information Systems Bled, Slovenia, 2001. June 27-29 [cited 2006 Feb 12] Available from URL : http://verdi.unisg.ch/ org/iwi/iwi_pub.nsf/wwwPublRecentEng/178AB6AC406E8B7FC1256E4D006B5228/ $file/041_Puschmann.pdf
17. Morris LA, Pines WL. Regulation of pharmaceutical promotion in the twenty-first century. Drug Inf J 2000 34 : 861 73.
18. Lerer L. Pharmaceutical marketing segmentation in the age of the Internet. Int J Med Mark 2002 2 : 159 66.
19. Faunce T, Doran E, Henry D, Drahos P, Searles A, Pekarsky B et al. Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy. Globalization Health 2005 1 15.
20. Orsenigo L, Pammolli F, Riccaboni M. Technological change and network dynamics: lessons from the pharmaceutical industry. Research Policy 2001 30 : 485 508.
21. Gassmann O, Reepmeyer G. Organizing pharmaceutical innovation: from science-based knowledge creators to drug-oriented knowledge brokers creativity and innovation management 2005 14 : 233 45.
22. Australian Research Council Discovery Project DP0877633 Doran E, Henry D Moynihan R. Pharmaceutical Promotion: Productive or Problematic? [Cited 2008 Sep]; Available from URL : http:///www.arc.gov.au/pdf/DP08/DP08_NewcastleU.pdf